Closure of Trading Window under SEBI (Prohibition of Insider Trading Regulations) 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals Ltd has informed the BSE that the trading window for dealing in its securities will remain closed from 1st October 2025. The closure is in line with SEBI's Insider Trading Regulations and applies to all Designated Persons and their immediate relatives, who are prohibited from trading in the company's shares during this period. The window will reopen only after 48 hours from the declaration of the unaudited financial results for the quarter and half year ending 30 September 2025. The date of the Board Meeting to approve these results will be communicated separately. The intimation is signed by Whole Time Director Dhananjaya Alli (DIN: 00610909).
This is a routine regulatory filing with no direct impact on shareholders or stock price. It simply prevents insiders from trading ahead of the upcoming quarterly results announcement, ensuring fair disclosure.